HelixNano

Using mRNA to modify biology at the push of a button

First Investment: 2017

HelixNano is developing new ways to manipulate messenger RNA, the molecule that delivers information from genes to the cell’s protein factories. One of HelixNano’s advances makes mRNA vaccines more targeted and more powerful; the company is using this technique to advance a mutation-resistant, second-generation vaccine against the SARS-CoV‑2 virus that causes Covid-19.

Explore Companies

Recursive Superintelligence

Self-improving automation of knowledge discovery

Quantum Motion

Fast-tracking the development of fault-tolerant quantum computer systems

Pacific Fusion

Reducing the cost and complexity of generating electricity from nuclear fusion

Sidewinder Therapeutics

Advancing precision bispecific antibody-drug conjugates to treat cancer